mRNA vaccine: What else is possible after Covid?
Overview
mRNA vaccine technology has shown unprecedented success in the COVID-19 pandemic, saving millions of lives worldwide. This technology creates immunity by instructing cells to produce specific proteins. Post-COVID, mRNA technology is opening up new possibilities in the treatment of other infectious diseases, cancers, and genetic diseases. This article discusses the mechanism of action of mRNA vaccines, their potential applications post-COVID, challenges, and their potential in the context of Bangladesh.
How does mRNA vaccine work?
mRNA (messenger ribonucleic acid) vaccines instruct the cell's ribosomes to make a specific protein, such as the spike protein of the Covid-19 virus. This protein activates the immune system to produce antibodies, which prevent future infection with the virus. mRNA does not enter the cell's nucleus, so it does not change DNA. In the Covid vaccine, mRNA enters the cell via lipid nanoparticles and is quickly broken down after its work is done.
Potential application of mRNA vaccines after Covid
The success of mRNA vaccines in COVID-19 has opened the door to other applications of this technology. Below are some potential applications:
1. Vaccines for other infectious diseases
- Influenza (flu): mRNA vaccines can provide broad protection by targeting the influenza hemagglutinin protein. Traditional flu vaccines take 6 months to develop, but mRNA vaccines can be developed faster.
- HIV: Australian researchers are using mRNA to try to knock the HIV virus out of its dormant state and eliminate it. This is a significant step towards a cure for HIV.
- Zika, Ebola, and Malaria: mRNA vaccines show the potential to create rapid and effective vaccines against these diseases.
- Self-amplifying mRNA (saRNA): This new technology is more effective at lower doses. SaRNA vaccines have already been approved for malaria in India and Covid in Japan.
2. Cancer treatment
- Personalized cancer vaccines: mRNA vaccines can activate the immune system by targeting specific neoantigens in tumors. Such vaccines are in clinical trials for melanoma and pancreatic cancer.
- Immunotherapy: Researchers at BioNTech are training the immune system by presenting cancer cell antigens through mRNA.
3. Genetic diseases
mRNA technology can be used to replace defective proteins in genetic diseases. For example, it shows potential in treating diseases such as cystic fibrosis or hemophilia.
4. Rapid vaccine production
The biggest advantage of mRNA vaccines is their rapid production capacity. Once the genome sequence of the new virus is known, it is possible to produce a vaccine within a few weeks. This will play a crucial role in combating future pandemics.
Picture: istockphoto.com
Advantages of mRNA technology
- Rapid development: mRNA vaccines can be designed and produced faster than traditional vaccines.
- Flexibility: It is possible to change the mRNA sequence for any protein.
- Safety: mRNA does not modify DNA and is broken down quickly in cells.
- Strong immune response: It activates both humoral and cellular immunity.